13F HOLDINGS REPORT
Vida Ventures Advisors, LLC
Quarter ended Q3 2024 · Filed October 8, 2024 · Accession 0000950123-24-009559
Total Value
$138.6M
Positions
6
Other Managers
0
Confidential Omitted
No
Holdings (6)
| # | Issuer | Ticker / CUSIP | Shares | Value | % of Filing |
|---|---|---|---|---|---|
| 1 | Centessa Pharmaceuticals plc | CNTA | 3,931,818 | $62.9M | 45.36% |
| 2 | Tectonic Therapeutics, Inc. | TECX | 1,028,674 | $31.2M | 22.49% |
| 3 | Kyverna Therapeutics, Inc. | KYTX | 4,523,924 | $22.1M | 15.96% |
| 4 | Dyne Therapeutics, Inc. | DYN | 407,499 | $14.6M | 10.56% |
| 5 | Allogene Therapeutics, Inc. | ALLO | 1,798,163 | $5.0M | 3.63% |
| 6 | Kronos Bio, Inc. | 50107A104 | 2,765,314 | $2.8M | 2.00% |